77 related articles for article (PubMed ID: 2184908)
1. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
[TBL] [Abstract][Full Text] [Related]
3. Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal.
Yeh SP; Hsueh EJ; Yu MS; Wu H; Wang YC
Bone Marrow Transplant; 1999 Dec; 24(11):1207-11. PubMed ID: 10642810
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
5. Long-term oral ciprofloxacin for infection prophylaxis in allogeneic bone marrow transplantation.
de Witte T; Novakova I; Branolte J; Muytjens H; de Pauw B
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S48-52. PubMed ID: 2963998
[TBL] [Abstract][Full Text] [Related]
6. Infection prevention in autologous bone marrow transplantation and the role of protective isolation.
Dekker AW; Verdonck LF; Rozenberg-Arska M
Bone Marrow Transplant; 1994 Jul; 14(1):89-93. PubMed ID: 7951125
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
Lew MA; Kehoe K; Ritz J; Antman KH; Nadler L; Kalish LA; Finberg R
J Clin Oncol; 1995 Jan; 13(1):239-50. PubMed ID: 7799026
[TBL] [Abstract][Full Text] [Related]
8. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
10. [Early bacterial infections after allogenic bone marrow grafts].
Guyotat D; Plotton C; Archimbaud E; Fiere D; Fleurette J
Pathol Biol (Paris); 1988 Sep; 36(7):896-8. PubMed ID: 3059272
[TBL] [Abstract][Full Text] [Related]
11. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW; Singh S; Johnson RH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
[TBL] [Abstract][Full Text] [Related]
14. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
[TBL] [Abstract][Full Text] [Related]
15. Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients.
Schmeiser T; Kern WV; Hay B; Hertenstein B; Arnold R
Bone Marrow Transplant; 1993 Jul; 12(1):57-63. PubMed ID: 8374536
[TBL] [Abstract][Full Text] [Related]
16. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
[TBL] [Abstract][Full Text] [Related]
17. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
18. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.
Menichetti F; Felicini R; Bucaneve G; Aversa F; Greco M; Pasquarella C; Moretti MV; Del Favero A; Martelli MF
Bone Marrow Transplant; 1989 Sep; 4(5):489-92. PubMed ID: 2790326
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis in blood and marrow transplant recipients.
Yuen KY; Woo PC
Hematol Oncol; 2002 Jun; 20(2):51-62. PubMed ID: 12111868
[TBL] [Abstract][Full Text] [Related]
20. Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Lesse AJ; Freer C; Salata RA; Francis JB; Scheld WM
Am J Med; 1987 Apr; 82(4A):247-53. PubMed ID: 3555043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
